Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Issue Information

Issue Information CR Cancer Reports The cover image is based on the Review Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? by Varun Subramaniam Venkatesh and Emil Lou, https://doi.org/10.1002/cnr2.1185. Cover image ©Varun Venkatesh Images. This special issue highlights the role of cell-to-cell communication, especially Tunneling Nanotubes (TNTs), in cancer pathogenesis. In addition, it covers the potential of TNTs as therapeutic target to prevent and reduce cancer incidence. The issue has been compiled by Guest Editor Dr Eliseo Eugenin at University of Texas Medical Branch, TX. CR Cancer Reports A depiction that portrays some of the key histopathological features in glioblastoma; highly pleomorphic cells with admixed scattered karyorrhectic debris and anomalous angiogenesis. Cover image © Heidi Soliman Images. Editorial Board Editor-in-Chief Sathees C. Raghavan, PhD Nidhi Bansal, PhD, John Wiley & Sons Indian Institute of Science, Bangalore, India Julie Reisz Haines, PhD Associate Editors University of Colorado, Denver, USA B.S. Dwarakanath, PhD Shalini Singh, PhD Shanghai Proton and Heavy Ion Center, Shanghai, China The University of Texas MD Anderson Cancer Center, Yusuke Nakamura, MD, PhD Houston, TX Cancer Precision Research Center, JFCR, Tokyo, Japan Toyomasa Katagiri, PhD Haiyan Liu, PhD Institute for Genome Research, The University of National University of Singapore, Singapore Tokushima, Tokushima, Japan Jayant Sastri Goda, MD Douglas Hurst, PhD Advanced Centre for Treatment, Research & Education The University of Alabama School of Medicine, in Cancer, Navi Mumbai, India Birmingham, USA Argerie Tsimicalis, PhD Xingcai Zhang, PhD Ingram School of Nursing, McGill University, Massachusetts Institute of Technology, Cambridge, USA Montreal, Canada Siddharth Agrawal, MD Kevin Petrie, PhD King George's Medical University, Lucknow, India University of Stirling, Stirling, UK Sarah-Maria Fendt, PhD Nina Linde, PhD VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium Merck KGaA, Darmstadt, Germany Selma Bekri, PhD Samir Parekh, MD Icahn School of Medicine at Mount Sinai, New York, USA Icahn School of Medicine at Mount Sinai, New York, USA Gayatri Mukherjee, PhD Indian Institute of Technology, Kharagpur, India Advisory Board Eduardo Farias, PhD Robert Weinberg, PhD Icahn School of Medicine at Mount Sinai, New York, USA Whitehead Institute for Biomedical Research, Manish Muhuri, PhD Massachusetts Institute of Technology, Cambridge, USA Institute of Medical Biology, Singapore Kenneth Yamada, MD, PhD Nagraj Huilgol, MD National Institutes of Health, Bethesda, Maryland, USA Nanavati Hospital, Mumbai, India Samuel Waxman, MD Seema Gupta, PhD Icahn School of Medicine at Mount Sinai, New York, USA Georgetown University, Washington D.C., USA Geoffery Brown, PhD Ganesh Venkatraman, PhD University of Birmingham, Birmingham, UK Sri Ramachandra University, Chennai, India Doris Germain, PhD Gayathri R. Devi, PhD Icahn School of Medicine at Mount Sinai, New York, USA Duke University School of Medicine, Durham, USA Sharad Singhal, PhD Feng Liang, MD, PhD Beckman Research Institute of City of Hope, Duarte, USA Massachusetts General Hospital – Harvard Medical Josh Neman, PhD School, USA Keck School of Medicine of USC, LA, USA Cancer Reports (Online ISSN:2573-8348) is published online every 2 months for a total of 6 times per year, by Wiley Subscription Services, Inc., a Wiley Company, 111 River St., Hoboken, NJ 07030-5774. Copyright and Copying Copyright © 2019 Wiley Periodicals, Inc., a Wiley Company. All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means without the prior permission in writing from the copyright holder. Authorization to copy items for internal and personal use is granted by the copyright holder for libraries and other users registered with their local Reproduction Rights Organisation (RRO), e.g. Copyright Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA 01923, USA (www.copyright.com), provided the appropriate fee is paid directly to the RRO. This consent does not extend to other kinds of copying such as copying for general distribution, for advertising or promotional purposes, for republication, for creating new collective works or for resale. Permissions for such reuse can be obtained using the RightsLink “Request Permissions” link on Wiley Online Library. Special requests should be addressed to: permissions@wiley.com. Disclaimer The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information con- tained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised. For submission instructions, subscription, and all other information visit: http://wileyonlinelibrary.com/journal/cnr2. December 2019 | Volume 2 | Number 6 Special Issue: Role of Cell-to-Cell Communication in Cancer: New Features, Insights, and Directions Guest Editor: Eliseo Eugenin Editorial Role of cell-to-cell communication in cancer: New features, insights, and directions Eliseo A. Eugenin Original Article Macrophages enhance 3D invasion in a breast cancer cell line by induction of tumor cell tunneling nanotubes Kiersten P. Carter, Samer Hanna, Alessandro Genna, Daniel Lewis, Jeffrey E. Segall and Dianne Cox Method Report Importance of measuring endolysosome, cytosolic, and extracellular pH in understanding the pathogenesis of and possible treatments for glioblastoma multiforme Peter W. Halcrow, Nabab Khan, Gaurav Datta, Joyce E. Ohm, Xuesong Chen and Jonathan D. Geiger Reviews Current clinical management of patients with glioblastoma Stephen Lowe, Krishna P. Bhat and Adriana Olar Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? Varun Subramaniam Venkatesh and Emil Lou Tunneling nanotube-like structures in brain tumors Matthias Osswald, Erik Jung, Wolfgang Wick and Frank Winkler Role of endolysosomes and pH in the pathogenesis and treatment of glioblastoma Peter Halcrow, Gaurav Datta, Joyce E. Ohm, Mahmoud L. Soliman, Xuesong Chen and Jonathan D. Geiger Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools Silvana Valdebenito, Daniela D'Amico and Eliseo Eugenin Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer Matthias Holzlechner, Eliseo Eugenin and Brendan Prideaux Machine learning approaches to study glioblastoma: A review of the last decade of applications Jessica Valdebenito and Felipe Medina The cover image is based on the Review Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? by Varun Subramaniam Venkatesh and Emil Lou, https://doi.org/10.1002/cnr2.1185. Cover image ©Varun Venkatesh Images. This special issue highlights the role of cell-to-cell communication, especially Tunneling Nanotubes (TNTs), in cancer pathogenesis. In addition, it covers the potential of TNTs as therapeutic target to prevent and reduce cancer incidence. The issue has been compiled by Guest Editor Dr Eliseo Eugenin at University of Texas Medical Branch, TX. A depiction that portrays some of the key histopathological features in glioblastoma; highly pleomorphic cells with admixed scattered karyorrhectic debris and anomalous angiogenesis. Cover image © Heidi Soliman Images. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Reports Wiley

Issue Information

Cancer Reports , Volume 2 (6) – Dec 1, 2019
Download PDF
4 pages

Loading next page...
 
/lp/wiley/issue-information-So13MRp9wt

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
© 2019 Wiley Periodicals, Inc.
eISSN
2573-8348
DOI
10.1002/cnr2.1233
Publisher site
See Article on Publisher Site

Abstract

CR Cancer Reports The cover image is based on the Review Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? by Varun Subramaniam Venkatesh and Emil Lou, https://doi.org/10.1002/cnr2.1185. Cover image ©Varun Venkatesh Images. This special issue highlights the role of cell-to-cell communication, especially Tunneling Nanotubes (TNTs), in cancer pathogenesis. In addition, it covers the potential of TNTs as therapeutic target to prevent and reduce cancer incidence. The issue has been compiled by Guest Editor Dr Eliseo Eugenin at University of Texas Medical Branch, TX. CR Cancer Reports A depiction that portrays some of the key histopathological features in glioblastoma; highly pleomorphic cells with admixed scattered karyorrhectic debris and anomalous angiogenesis. Cover image © Heidi Soliman Images. Editorial Board Editor-in-Chief Sathees C. Raghavan, PhD Nidhi Bansal, PhD, John Wiley & Sons Indian Institute of Science, Bangalore, India Julie Reisz Haines, PhD Associate Editors University of Colorado, Denver, USA B.S. Dwarakanath, PhD Shalini Singh, PhD Shanghai Proton and Heavy Ion Center, Shanghai, China The University of Texas MD Anderson Cancer Center, Yusuke Nakamura, MD, PhD Houston, TX Cancer Precision Research Center, JFCR, Tokyo, Japan Toyomasa Katagiri, PhD Haiyan Liu, PhD Institute for Genome Research, The University of National University of Singapore, Singapore Tokushima, Tokushima, Japan Jayant Sastri Goda, MD Douglas Hurst, PhD Advanced Centre for Treatment, Research & Education The University of Alabama School of Medicine, in Cancer, Navi Mumbai, India Birmingham, USA Argerie Tsimicalis, PhD Xingcai Zhang, PhD Ingram School of Nursing, McGill University, Massachusetts Institute of Technology, Cambridge, USA Montreal, Canada Siddharth Agrawal, MD Kevin Petrie, PhD King George's Medical University, Lucknow, India University of Stirling, Stirling, UK Sarah-Maria Fendt, PhD Nina Linde, PhD VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium Merck KGaA, Darmstadt, Germany Selma Bekri, PhD Samir Parekh, MD Icahn School of Medicine at Mount Sinai, New York, USA Icahn School of Medicine at Mount Sinai, New York, USA Gayatri Mukherjee, PhD Indian Institute of Technology, Kharagpur, India Advisory Board Eduardo Farias, PhD Robert Weinberg, PhD Icahn School of Medicine at Mount Sinai, New York, USA Whitehead Institute for Biomedical Research, Manish Muhuri, PhD Massachusetts Institute of Technology, Cambridge, USA Institute of Medical Biology, Singapore Kenneth Yamada, MD, PhD Nagraj Huilgol, MD National Institutes of Health, Bethesda, Maryland, USA Nanavati Hospital, Mumbai, India Samuel Waxman, MD Seema Gupta, PhD Icahn School of Medicine at Mount Sinai, New York, USA Georgetown University, Washington D.C., USA Geoffery Brown, PhD Ganesh Venkatraman, PhD University of Birmingham, Birmingham, UK Sri Ramachandra University, Chennai, India Doris Germain, PhD Gayathri R. Devi, PhD Icahn School of Medicine at Mount Sinai, New York, USA Duke University School of Medicine, Durham, USA Sharad Singhal, PhD Feng Liang, MD, PhD Beckman Research Institute of City of Hope, Duarte, USA Massachusetts General Hospital – Harvard Medical Josh Neman, PhD School, USA Keck School of Medicine of USC, LA, USA Cancer Reports (Online ISSN:2573-8348) is published online every 2 months for a total of 6 times per year, by Wiley Subscription Services, Inc., a Wiley Company, 111 River St., Hoboken, NJ 07030-5774. Copyright and Copying Copyright © 2019 Wiley Periodicals, Inc., a Wiley Company. All rights reserved. No part of this publication may be reproduced, stored or transmitted in any form or by any means without the prior permission in writing from the copyright holder. Authorization to copy items for internal and personal use is granted by the copyright holder for libraries and other users registered with their local Reproduction Rights Organisation (RRO), e.g. Copyright Clearance Center (CCC), 222 Rosewood Drive, Danvers, MA 01923, USA (www.copyright.com), provided the appropriate fee is paid directly to the RRO. This consent does not extend to other kinds of copying such as copying for general distribution, for advertising or promotional purposes, for republication, for creating new collective works or for resale. Permissions for such reuse can be obtained using the RightsLink “Request Permissions” link on Wiley Online Library. Special requests should be addressed to: permissions@wiley.com. Disclaimer The Publisher and Editors cannot be held responsible for errors or any consequences arising from the use of information con- tained in this journal; the views and opinions expressed do not necessarily reflect those of the Publisher and Editors, neither does the publication of advertisements constitute any endorsements by the Publisher and Editors of the products advertised. For submission instructions, subscription, and all other information visit: http://wileyonlinelibrary.com/journal/cnr2. December 2019 | Volume 2 | Number 6 Special Issue: Role of Cell-to-Cell Communication in Cancer: New Features, Insights, and Directions Guest Editor: Eliseo Eugenin Editorial Role of cell-to-cell communication in cancer: New features, insights, and directions Eliseo A. Eugenin Original Article Macrophages enhance 3D invasion in a breast cancer cell line by induction of tumor cell tunneling nanotubes Kiersten P. Carter, Samer Hanna, Alessandro Genna, Daniel Lewis, Jeffrey E. Segall and Dianne Cox Method Report Importance of measuring endolysosome, cytosolic, and extracellular pH in understanding the pathogenesis of and possible treatments for glioblastoma multiforme Peter W. Halcrow, Nabab Khan, Gaurav Datta, Joyce E. Ohm, Xuesong Chen and Jonathan D. Geiger Reviews Current clinical management of patients with glioblastoma Stephen Lowe, Krishna P. Bhat and Adriana Olar Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? Varun Subramaniam Venkatesh and Emil Lou Tunneling nanotube-like structures in brain tumors Matthias Osswald, Erik Jung, Wolfgang Wick and Frank Winkler Role of endolysosomes and pH in the pathogenesis and treatment of glioblastoma Peter Halcrow, Gaurav Datta, Joyce E. Ohm, Mahmoud L. Soliman, Xuesong Chen and Jonathan D. Geiger Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools Silvana Valdebenito, Daniela D'Amico and Eliseo Eugenin Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer Matthias Holzlechner, Eliseo Eugenin and Brendan Prideaux Machine learning approaches to study glioblastoma: A review of the last decade of applications Jessica Valdebenito and Felipe Medina The cover image is based on the Review Tunneling nanotubes: A bridge for heterogeneity in glioblastoma and a new therapeutic target? by Varun Subramaniam Venkatesh and Emil Lou, https://doi.org/10.1002/cnr2.1185. Cover image ©Varun Venkatesh Images. This special issue highlights the role of cell-to-cell communication, especially Tunneling Nanotubes (TNTs), in cancer pathogenesis. In addition, it covers the potential of TNTs as therapeutic target to prevent and reduce cancer incidence. The issue has been compiled by Guest Editor Dr Eliseo Eugenin at University of Texas Medical Branch, TX. A depiction that portrays some of the key histopathological features in glioblastoma; highly pleomorphic cells with admixed scattered karyorrhectic debris and anomalous angiogenesis. Cover image © Heidi Soliman Images.

Journal

Cancer Reports – Wiley

Published: Dec 1, 2019

There are no references for this article.